Governing synthetic biology for global health through responsible research and innovation

Systems and Synthetic Biology

Volumn 7, Issue 3, 2013, Pages 139-150

  Douglas, Conor M W ^a,b   Stemerding, Dirk ^a  

^a Rathenau Institute KNAW   (Netherlands)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Global health; Governance; Policy; Responsible research and innovation; Synthetic biology

Indexed keywords

EID: 84881542683     PISSN: 18725325     EISSN: 18725333     Source Type: Journal    
DOI: 10.1007/s11693-013-9119-1     Document Type: Article

References (38)

1. Betten AW, Roelofsen A, Broerse JEW (2013) Interactive learning and action: realizing the promise of synthetic biology for global health. Syst Synth Biol. doi: 10. 1007/s11693-013-9113-7.
2. Brown TM, Cueto M, Fee E (2006) The World Health Organization and the transition from "international" to "global" public health. Am J Public Health 96(1): 62-72.
3. Carothers JM (2013) Design-driven, multi-use research agendas to enable applied synthetic biology for global health. Syst Synth Biol. doi: 10. 1007/s11693-013-9118-2.
4. Douglas CMW, Stemerding D (2012) Final report. SYBHEL Workshop: synthetic biology for global health a policy discussion, The Hague, 9-10 Feb 2012.
5. Gagnon MA, Lexchin J (2008) The cost of pushing pills: a new estimate of pharmaceutical promotion expenditures in the United States. PLoS Med 5(1): e1.
6. Garrett L (2007) The challenge of global health. Foreign Affairs. Retrieved from http://www. foreignaffairs. com/articles/62268/laurie-garrett/the-challenge-of-global-health. Jan/Feb 2007.
7. Hansen J, Metzler I (2012) Governing bio-objects: a research agenda. Croat Med J 53: 80-82.
8. Henkel J, Reitzig M (2008) Patent sharks. Harv Bus Rev 86(6): 129-133.
9. Hollis A (2008) The health impact fund: a useful supplement to the patent system? Public Health Ethics 1(2): 124-133.
10. Hollis A (2013) Synthetic biology: ensuring the greatest global value. Syst Synth Biol. doi: 10. 1007/s11693-013-9115-5.
11. Hollis A, Pogge T (2008) The health impact fund: making new medicines accessible for all (A report of Incentives for Global Health), p 152. Retrieved from http://machif. com/wp-content/uploads/2012/11/hif_book. pdf.
12. Johnson RA (2012) Enabling synthetic biology in global health: a strategic roadmap for innovative social benefit infrastructure, scalable networks and commons, and novel tools and platforms. SYBHEL workshop booklet: synthetic biology for global health a policy discussion, The Hague, 9-10 Feb 2012.
13. Koplan JP, Bond TC, Merson MH, Reddy KS, Rodriguez MH, Sewankambo NK, Wasserheit JN (2009) Towards a common definition of global health. Lancet 373(9679): 1993-1995.
14. Kefauver E (1965) In a few hands. Penguin, Harmondsworth, UK.
15. Landrain T, Meyer M, Perez AM, Sussan R (2013) Do-it-yourself biology: challenges and promises for an open science and technology movement. Syst Synth Biol. doi: 10. 1007/s11693-013-9116-4.
16. Metzler I, Webster A (2011) Bio-objects and their boundaries: governing matters at the intersection of society, politics, and science. Croat Med J 52: 648-650.
17. Owen R, Macnaghten P, Stilgoe J (2012) Responsible research and innovation: from science in society to science for society, with society. Sci Public Policy 39(6): 751-760. doi: 10. 1093/scipol/scs093.
18. Oye KA, Wellhausen R (2009) The intellectual commons and property in synthetic biology. In: Schmidt M et al (eds) Synthetic biology. Springer, Berlin, pp 121-139.
19. Pogge T, Rimmer M, Rubenstein K (2010) Incentives for global public health. Cambridge University Press, Cambridge.
20. Reiling KK, Renninger NS, McPhee DJ, Fisher KJ, Ockey DA (2006) Conversion of amorpha-4, 11-diene to artemisinin and artemisinin precursors. Retrieved from http://www. google. com/patents/US20060270863.
21. Rooke J (2013) Synthetic biology as a source of global health innovation. Syst Synth Biol. doi: 10. 1007/s11693-013-9117-3.
22. Rutz B (2009) Synthetic biology and patents: a European perspective. EMBO Rep 10: S14-S17.
23. Smits M, Brom F, ter Gast E, Klaassen P, Harnmeijer J et al (2008) Extending the pipeline: toward a comprehensive and coordinated EU approach to poverty related diseases. STOA.
24. van den Belt H (2012) Synthetic biology, patenting, health and global justice. Syst Synth Biol. doi: 10. 1007/s11693-012-9098-7.
25. Vermeulen N, Tamminen S, Webster A (eds) (2012) Bio-objects. Life in the 21st century. Ashgate, Surrey.
26. Vohra P, Blakey G (2013) Easing the global burden of diarrhoeal disease - Can synthetic biology help? Syst Synth Biol (this issue).
27. von Schomberg R (2013) A vision of responsible research and innovation. In: Owen R, Bessant J, Heintz M (eds) Responsible innovation: Managing the responsible emergence of science and innovation in society. Wiley, Chichester, pp 51-74.
28. World Health Organization (2005) Life science research: opportunities and risks for public health. Mapping the issues. Retrieved from http://www. who. int/csr/resources/publications/deliberate/WHO_CDS_CSR_LYO_2005_20/en/.
29. Zhang JY (2012) The art of trans-boundary governance: the case of synthetic biology. Syst Synth Biol. doi: 10. 1007/s11693-012-9097-8.
30. Amyris (2012a) Our story. http://www. amyris. com/en/about-amyris/our-story. Accessed 11 Jan 2012.
31. Amyris (2012b) Artemisinin. http://www. amyris. com/index. php/en/markets/artemisinin. Accessed 11 Jan 2012.
32. BioBricks Foundation (2013a) Main page. http://partsregistry. org/Main_Page. Accessed 7 Jan 2012.
33. BioBricks Foundation (2013b) Frequently asked questions. https://biobricks. org/bpa/faq/#top. Accessed 19 March 2012.
34. European Patent Office (1997) The European Patent Convention. Retrieved 30 May 2013 from http://www. epo. org/law-practice/legal-texts/html/epc/2010/e/ar63. html.
35. European Patent Office (2007a) Scenarios for the future. Retrieved March 19, 2013, from http://www. epo. org/news-issues/issues/scenarios. html.
36. European Patent Office (2007b) Trees of knowledge. http://www. epo. org/news-issues/issues/scenarios/scenarios/trees-of-knowledge. html. Accessed 5 April 2013.
37. OneWorld Health (2012) History. http://www. oneworldhealth. org/history. Accessed 11 Jan 2012.
38. Zagaya (2012) What we do. http://dev. amyris. org/what-we-do. Accessed 11 Jan 2012.